UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Proto Labs, Inc. (NYSE:PRLB – Free Report) by 4.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,189 shares of the industrial products company’s stock after purchasing an additional 3,247 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.33% of Proto Labs worth $2,355,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. FMR LLC grew its holdings in shares of Proto Labs by 23.4% during the third quarter. FMR LLC now owns 29,474 shares of the industrial products company’s stock worth $866,000 after purchasing an additional 5,584 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in Proto Labs during the 3rd quarter worth about $753,000. Pacer Advisors Inc. grew its holdings in Proto Labs by 44,804.1% during the 3rd quarter. Pacer Advisors Inc. now owns 573,874 shares of the industrial products company’s stock worth $16,855,000 after acquiring an additional 572,596 shares during the last quarter. Intech Investment Management LLC acquired a new stake in Proto Labs in the 3rd quarter valued at about $232,000. Finally, Connor Clark & Lunn Investment Management Ltd. raised its stake in shares of Proto Labs by 217.6% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 68,403 shares of the industrial products company’s stock worth $2,009,000 after acquiring an additional 46,866 shares during the last quarter. 84.54% of the stock is owned by institutional investors and hedge funds.
Proto Labs Trading Down 1.5 %
Shares of NYSE PRLB opened at $43.59 on Friday. Proto Labs, Inc. has a 1 year low of $25.75 and a 1 year high of $45.15. The firm’s 50-day moving average is $35.58 and its 200-day moving average is $32.27. The firm has a market capitalization of $1.07 billion, a PE ratio of 46.37 and a beta of 1.45.
Analyst Upgrades and Downgrades
PRLB has been the topic of several research analyst reports. Craig Hallum increased their price target on shares of Proto Labs from $30.00 to $36.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Needham & Company LLC reiterated a “hold” rating on shares of Proto Labs in a research report on Friday, November 1st. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $40.00 target price on shares of Proto Labs in a research note on Monday, November 4th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, Proto Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $40.33.
Get Our Latest Stock Analysis on PRLB
Proto Labs Company Profile
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Featured Stories
- Five stocks we like better than Proto Labs
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Dividend Payout Ratio Calculator
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.